Jeffrey Scott Riley, Director at Gain Therapeutics, Inc. (GANX), bought 30,000 shares at $3.86 ($116K) on 2024-03-28, disclosed to the SEC on 2024-04-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| SYN | BUY | 2013-01-03 | $10K | — | Filing → |